Odyssey Therapeutics, Inc. (ODTX)
NCM · Healthcare · Biotechnology
$19.08
+0.42%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$917.0M
Shares Outstanding
48.1M
P/S (TTM)
319x
Exchange
NCM
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 1.9M | 959K | 0.00 | 0.00 |
| Operating Income | (44.8M) | (42.5M) | (39.7M) | (46.7M) |
| Net Income | (38.4M) | (41.2M) | (38.3M) | (52.8M) |
| Diluted EPS | $-1.39 | $-1.50 | $-0.81 | $-1.74 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 1.0M | 4.5M | 3.0M |
| Operating Income | (122.8M) | (133.4M) | (135.2M) | (161.2M) |
| Net Income | (124.7M) | (125.9M) | (129.3M) | (148.6M) |
| Diluted EPS | $-4.52 | $-1.32 | $-4.73 | $-5.39 |